Overview

This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process.

It addresses key aspects of preclinical drug evaluation through the study of:

• Drug discovery and development
• Safety pharmacology
• Mechanisms of drug-induced toxicities
• Regulatory affairs
• Bioanalytical sciences

It will give you state-of-the-art training in preclinical toxicology, with an emphasis on the molecular in vitro and in vivo aspects of toxicology and safety pharmacology assessments.

As part of the programme you will undertake an original research project that will be the basis of your dissertation.

Delivered at the Institute of Cancer Therapeutics, an internationally renowned research institution, the programme gives you the skills you need for a career in the pharmaceutical industry or regulatory bodies, along with the foundations for PhD study.

Drug toxicology and safety pharmacology lies at the heart of the chemical and pharmaceutical industries, and demand for highly skilled practitioners in this field is extremely high.

Learning and assessment

A wide variety of teaching methods appropriate to the learning outcomes of the individual modules are employed throughout the programme and are supported by the virtual learning environment provided by the University.

Students will experience lectures from ICT research/teaching staff and visiting clinicians and industrial researchers, small group workshops, one-to-one tutorials and practical classes.

Students will also attend the Institute of Cancer Therapeutics Research Seminar programme. Self-directed independent learning forms a significant component at MSc level; students will be supported to develop the attributes and skills needed for life-long learning and continued professional development.

Directed private study will involve students in a variety of activities, which include directed reading of selected textbooks and specified source literature, use of the virtual learning environment (directed web-based materials), report writing, preparing presentations to deliver to peers, and other assignments.

Career prospects

The largest destination of our graduates is enrolment in PhD studies (47%) including here at Bradford, as well as King’s College London, Cambridge, Manchester, Liverpool, Leeds, Newcastle, Portsmouth and Sheffield.

Career destination of our graduates include the NHS, Covance, Envigo, St James Hospital Leeds, Cyprotex, Chiltern, Perrigo, Dewsbury & District Hospital, Liverpool Institute of Translational Medicine, and Public Health England.